Financial information January - March 2025 Net sales amounted to TSEK 23,499 KSEK (12,120), a 94 percent increase. Sales of instruments/other were TSEK 9,237 (4,864), a 90 percent increase.

"In January–March 2025, our net sales increased by 14.9 percent to EUR 354.6 (308.5) million and operating profit increased by 39.1 percent to EUR 77.9 (56.0) million. The year 2025 has started ...

Net sales increased to SEK 218.6 million (186.0), corresponding to growth of 18 percent in SEK and 16 percent in local currencies. Organic growth amounted to 14 percent in local currencies.

Net sales increased to SEK 218.6 million (186.0), corresponding to growth of 18 percent in SEK and 16 percent in local currencies. Organic growth amounted to 14 percent in local currencies. The ...

Profit (loss) after financial items was TSEK -35,522 (-28,719). Earnings per-share were SEK -0.27 (-0.23). Cash and cash equivalents as of March 31, 2025, were TSEK 62,059 (116,856).

Order intake for the first quarter increased by 97% to SEK 930 m (473). Organically, order intake increased by 12%, acquired growth was 89% and currency effects impacted by -4% Net sales increased by ...

This growth comes after a sluggish February 2025 and was led by improved performance in group business segments, although individual policy sales remain under pressure. The recovery in March this ...

Hillerstorp 23rd of April 2025, 12:30 CET JANUARY - MARCH Order intake in the quarter decreased by 4 percent compared with the same period last year and amounted to 69,5 (72,3) MEUR. Adjusted for ...

LUND, Sweden, April 24, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced its interim report for January-March 2025. Peter Nicklin ...

GOTHENBURG, Sweden, April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattias ...

Marriage Prediction: Married Life, Mangal dosha & Remedies.